Cargando…
Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal
Insulin resistance (IR) in skeletal muscle is a prerequisite for type 2 diabetes and is often associated with obesity. IR also develops alongside muscle atrophy in older individuals in sarcopenic obesity. The molecular defects that underpin this syndrome are not well characterized, and there is no l...
Autores principales: | Cleasby, M. E., Jarmin, S., Eilers, W., Elashry, M., Andersen, D. K., Dickson, G., Foster, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Physiological Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962614/ https://www.ncbi.nlm.nih.gov/pubmed/24473441 http://dx.doi.org/10.1152/ajpendo.00586.2013 |
Ejemplares similares
-
miRNA Transcriptome of Hypertrophic Skeletal Muscle with Overexpressed Myostatin Propeptide
por: Javed, Ruheena, et al.
Publicado: (2014) -
Urocortin 3 activates AMPK and AKT pathways and enhances glucose disposal in rat skeletal muscle
por: Roustit, Manon M, et al.
Publicado: (2014) -
Development of antisense-mediated myostatin knockdown for the treatment of insulin resistance
por: Eilers, Wouter, et al.
Publicado: (2021) -
Enhanced Muscle Growth by Plasmid-Mediated Delivery of Myostatin Propeptide
por: Hu, Shengwei, et al.
Publicado: (2010) -
Recent advances in understanding glucose transport and glucose disposal
por: Olson, Ann Louise, et al.
Publicado: (2020)